Continue to Site

Supreme Court declines review of Baxter/Fresenius patent row

May 19, 2014 by Brad Perriello

Supreme Court declines review of Baxter/Fresenius patent row

The U.S. Supreme Court today put an end to a patent infringement lawsuit between Baxter and Fresenius when it declined to review the case.

The Supremes’ decision to deny certiorari in Baxter et al v. Fresenius et al means last year’s reversal of Baxter’s win over dialysis device rival Fresenius will stand. Read more

Medtronic, Edwards ink $750M heart valve settlement

May 20, 2014 by Brad Perriello

Medtronic inks $750M settlement with Edwards Lifesciences

Medtronic agreed to pay $750 million to Edwards Lifesciences to put to rest their international patent infringement war over transcatheter aortic valve implants and other technologies.

The deal includes a provision that will see Medtronic pay royalties through April 2022 of at least $40 million annually. It also puts to rest all other pending litigation between the medical device companies. Neither company admitted to any infringement as part of the settlement. Read more

Pa. Supreme Court to review $28M Zimmer verdict

May 22, 2014 by Brad Perriello

Pa. Supreme Court to review $28M Zimmer verdict

Zimmer will get a chance to plead its case before Pennsylvania’s highest court as it seeks to overturn a $28 million verdict against it in a lawsuit brought by a knee implant patient who said she re-injured her joints while making a Zimmer promotional video.

The Keystone State’s Supreme Court yesterday said it will review a lower court’s handling of expert witness testimony and jury instructions in the case, Margo Polett and Dan Polett v. Public Communications Inc. et al. Read more

Laid off Italian workers sue Haemonetics

May 23, 2014 by Brad Perriello

Laid off Italian workers sue Haemonetics

Haemonetics said workers at a plant in Italy it’s planning to close as part of its global restructuring sued the blood management company in February.

The closure of the plant in Ascoli-Piceno, Italy, is part of a series of moves that includes closures for plants in Haemonetics’ home town of Braintree, Mass., as well as a facility in Scotland. Read more